Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-24-132130·ALX ONCOLOGY HOLDINGS INC
Schedule 13G ownership disclosure
ALX Oncology Holdings, Inc.
Common Stock, par value $0.001 per share · CUSIP: 00166B105
Event date: 2024-12-18
- Filing-level shares
- 3,426,929.00
- Percent of class
- 6.5%
- HBM Healthcare Investments (Cayman) Ltd.
Shares: 3,426,929.00 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-132130
- Form type
- SCHEDULE 13G
- Filer
- ALX ONCOLOGY HOLDINGS INC
- CIK
- CIK 1810182
- Filed
- Dec 27, 2024
- Reporting period
- Dec 18, 2024
- Description
- Schedule 13G beneficial ownership